Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Fiercebiotech

Published November 13, 2026 · Updated November 14, 2026

ARPA-H bets $4.9 million on ibogaine for PTSD treatment in veterans | Fierce Biotech

Read the full story at Fiercebiotech

Ibogaine is a naturally occurring psychedelic drug that researchers have studied as a potential treatment for opioid dependence and for depression and.

Surfaced by this Google Alert

  • Psychedelic biotech